See the latest vacancies and find out about working for MSF UKJobs in the UK
MSF Scientific Days 2020: Guidelines for submitting a research abstract
Total abstract wordcount: 400 words.
Submission deadline: 8th January 2020.
Your abstract should clearly and concisely give enough information about your research project to allow a reader to understand: why your research was needed; what you did; what you found out; and, importantly, what your findings mean for patients, MSF operations, or more widely.
Why was your research needed and what was your aim in doing it?
- Please describe the relevant background e.g. for MSF projects, detail why MSF is present in the region, what the project involves, and the setting (e.g. community, clinic, or hospital).
- Programme descriptions: the introduction must describe what your programme is and what it aims to do.
- You need to explain why this study/medical programme is needed – what information gap is it addressing/what would have happened without it?
- Describe the aim of the study/ medical programme and name the methodology (e.g. in a prospective cohort study, we aimed to establish whether... or in this programme description, we assessed.).
What did you do?
- describe what was done
- how the data was collected
- how data were analysed
- ensure your comparison group is clear.
- describe how you analysed the programme.
- avoid duplicating information in introduction and methods sections;
- Include any comparison group or programme if available.
What did you find out?
- Research studies: give primary outcomes, relate to aims stated in the introduction and to the methods described in the methods section – do not include results from work not described in the methods section.
- Programme descriptions: describe the outcomes of the programme, relate to aims stated in the introduction.
What should MSF or others do with your results?
Your conclusions should describe the implications of your work and any recommendations you may have for its future.
- Explain the significance of your main findings – why are they interesting? Are you the first to report this? Is this the largest cohort? Is this a unique cohort? Don’t just repeat your results again.
- Explain the implications (potential impact) of your study/programme – what this means for practice, policy or advocacy for MSF or others. Do not overstate your implications and ensure that any conclusions relate directly to the results you report.
- How would you like your results to be used by MSF? Propose next steps and a way forward (avoid saying "more research is needed...").
- Please include any limitations of your study/programme.
Assistance is available to review/assist in abstract writing. If you require this, please contact firstname.lastname@example.org as early as possible.
- Abstract review
Abstracts are rated according to: quality of scientific content, relevance and importance for a medical humanitarian audience, novelty of topic/findings, and rarity of topic – some topics, such as maternal health, are under-represented in MSF research and abstracts on such topics receive extra consideration.
All abstracts are considered for the International (London), Asia, Southern Africa and Latin America events for either poster or oral presentation.
Poster authors may also be offered a 1-minute opportunity on stage to present their poster.
- Abstract editing
Abstracts accepted for oral presentations will be edited. The aim is to ensure that presenters are fully prepared to meet questions that may be raised during the conference and to ensure that MSF research is presented clearly and appropriately.
Authors must be available to revise abstracts and presentation slides according to the timeframes below. Please note that the offer of an oral presentation or poster involves commitment by authors to meet deadlines and to respond to points raised by the Editorial Committee.
Abstracts will be edited for English language readability, scientific clarity, consistency, and adherence to abstract guidelines (see Content section above).
Edited abstracts will include questions/points raised by the Editorial Committee – these must be addressed in the abstract revision.
Note - poster abstracts are not published and therefore not edited. Authors will receive an edited version of their title and author affiliations to check for inclusion in the conference booklet.
- Presentation / poster editing
Presentations and posters are not edited unless they are sent early and assistance is requested. However, they will be reviewed to ensure that poster and presentation guidelines (sent to authors) are met – in particular around ethics statements, image use (author and copyright information included, including for maps; consent and ethics of using images of people or patients, particularly children), and clarity/accuracy of English language.
- Presentation/poster presentation practice
All oral presenters must ensure they are fully prepared to present to an in-person audience of c300 and an online audience of 1000s; so public speaking training is highly recommended.
Presentation practice for presenters will be available either in person or via Skype prior to MSF Scientific Days International. To take advantage presenters must register in advance by emailing email@example.com with a subject title of ‘presentation coaching’.
Poster authors who are offered an oral spot to present their poster may also attend coaching for their 1-minute presentation, either in person or online, and should register as above.
- Content sharing
All abstracts, posters, slides, and videos of oral presentations will be shared on an open access gateway at https://f1000research.com/gateways/MSF/scidays. Posters will be shared in advance of the conference and tweeted via @msfsci. Highlights of the day will be written up for blogs and potentially further publication.
Abstract submission deadline: 8th January 2020
If you have been successful in securing a poster or an oral presentation at the MSF Scientific Days International (London) event you will be contacted by 10th February 2020 and asked to confirm participation.
If you have not been successful, you will be contacted by 24th February, however you may still secure a place at the Asia, Latin America or Southern Africa events, for which timelines are yet to be set.
Abstract editing – oral presentation/poster titles
Poster titles will be edited in week commencing 10th February. Abstracts will be edited in the two weeks commencing 18th February. In both cases applicants will have 1 week to respond to queries – the corresponding authors must be available to revise and respond to questions during this time. If there is any difficulty in responding to the points raised, authors should contact the MSF Scientific Days team (firstname.lastname@example.org) as soon as possible.
Oral presentations/posters – assistance deadline
The deadline for requesting assistance with posters is 1st April.
The deadline for requesting assistance with presentations is 17th April.
Oral presentations/posters – submission deadline
Files for posters must be sent by 13th April.
Slides or other materials for oral presentations must be submitted by 1st May.
Authors must be available in the following week to respond to any comments/queries.
MSF abstracts must have had ethics oversight and been approved for submission to MSF Scientific Days by the Medical Director from the Operational Centre responsible for the research.
Please see the MSF Ethics Review Board (ERB) for guidance.
For research from other organisations, abstracts should have the relevant Ethics Committee oversight.
In the submission system, you will need to choose from one of the options below:
- Approved by an Ethics Review Board (ERB) - please specify:
- Meets the exemption criteria for ERB review - it was conducted with permission from:
- Other, please explain:
- Conflicts of interest
You will be asked to declare any conflicts of interest. Failure to disclose these might lead to withdrawal of abstracts or presentations from MSF Scientific Days. All conflicts of interest will be published in the conference booklet.
A conflict of interest exists when professional judgement concerning a primary interest (such as patients’ welfare or validity of research) may be influenced by a secondary interest (such as financial gain).
All authors must disclose any financial and personal relationships with other people or organisations that could inappropriately influence (bias) their work. Examples of financial conflicts include employment, consultancies, stock ownership, honoraria, paid expert testimony, patents or patent applications, and travel grants, all within 3 years of beginning the work submitted.
Financial relationships are easily identifiable, but conflicts can also occur because of personal relationships or rivalries, academic competition, or intellectual beliefs. A conflict can be actual or potential, and full disclosure is best practice.
Agreements between authors and study sponsors that interfere with authors’ access to all of a study’s data, or that interfere with their ability to analyse and interpret the data and to prepare and publish work independently, may represent conflicts of interest, and should be avoided.
All submissions must include disclosure of all relationships that could be viewed as presenting a potential or actual conflict of interest.
If there are no conflicts of interest, authors should tick the box to state that there are none.
Please note, all submitted MSF abstracts will be sent to the relevant Medical Director so that they are aware of what has been submitted.
- Data reporting standards
- If you have quantitative data, give actual numbers, not only percentages. Do not use phrases like ‘around half’ unless supported by underlying numbers. Ensure that the denominator is clear throughout the analysis and include where needed.
- Means need standard deviations (SDs); medians need interquartile ranges (IQRs). Give 95% confidence intervals (CIs) and p-values where appropriate.
Get in touch
If you have any questions, please get in contact with us: email@example.com